Prot# AC-055C302: Prospective, Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients with Ischemic Digital Ulcers Associated with Systemic Sclerosis. DUAL

Project: Research project

Project Details

StatusFinished
Effective start/end date2/10/122/10/15

Funding

  • Actelion Ltd. (AC-055C302)